Stockbroking Services

Shard Capital Stockbrokers provide financial advice and services to private and high-net-worth clients as well as family offices and institutions. They offer discretionary, advisory and execution only services over a range of UK and international equities, CFDs and collective investments, including participation in smaller company equity placements and fundraisings. Their range of accounts cater for all investor types, with stockbroking services available either online or over the phone.

Shard Capital Stockbrokers have been recognised for their outstanding financial advisory services, most recently at the 2017 Online Personal Wealth Awards where they won the Best Advisory Service accolade.

Financial advisory

Shard Capital Stockbrokers embrace technology and new concepts that are suited to traversing the fast-evolving financial advisory services industry and markets. The robust investment process, supported by an experienced and skilled investment committee, is focused on meeting individual client objectives, whilst considering their financial position and attitude to risk. A broad network ensures that they achieve top class execution and have a strong flow of deals to select from.

Find out how Shard Capital Stockbrokers can help you by taking a look at our range of financial advisory services below


image description

Private Investors

Private Investors

For individuals seeking a range of products and services for all levels of investment experience

image description



Select if you are an IFA, wealth manager or family office

image description

Corporate clients

Corporate clients

Select if you are looking to open an investment account for your company

spotlight image

What's the buzz in the alternative energy market?

Read more >

Things are speeding up in the electric car market:

image descriptionFollow us
image description

In Search of a Matador

Check out our Fixed Income Fund's macro update for this month >


Motif Bio Plc - Exercise of Warrants

Motif Bio plc, a clinical stage biopharmaceutical company specialising in developing novel antibiotics, announced that it has received notification from warrant holders to exercise warrants representing 183,031 ordinary shares of 1p each (“Ordinary Shares”) in the Company at an exercise price of 32.20p per warrant for total consideration of £58,935.98.   Application has been made for […] Read more

Keras Resources Plc - Pilbara Gold Presentation London 23 November 2017

Mr Dave Reeves will be in London on Thursday 23 November 2017 presenting on the Warrawoona Gold Project (the “Project”), which is 100% owned by Calidus Resources, in which Keras is the major shareholder. The Project lies in the heart of the Pilbara and the presentation will be an excellent chance for existing Keras shareholders […] Read more

Motif Bio - Secures up to US$20 million debt financing

London and New York, Motif Bio plc (AIM/NASDAQ: MTFB), a clinical stage biopharmaceutical company specialising in developing novel antibiotics, announced today that the Company has entered into an agreement for up to US$20 million in debt financing with Hercules Capital, Inc. (NYSE: HTGC), a leader in customised debt financing for companies in life sciences and […] Read more